Infection Control Market, By End-user (Hospitals, Clinics, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Laboratories, Others), By Product (Sterilization, Cleaning and Disinfection, Personal Protective Barriers, Endoscope Reprocessing, Anti-Microbial Surfaces, and Others), By Region Analysis - Global Analysis And Industry Forecast Report Till 2030.

The Infection Control Market is projected to grow from $49.97 billion to $65.20 billion, at a CAGR of 3% during the forecast period 2021-2030.

Infection-prone diseases are caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi. The disease can be spread from one person to another directly or indirectly through infected or non-sterile surgical or medical devices used to treat people, or through being in an infected environment in a health care facility. Infection control, therefore, emerges as a preventable measure to prevent these infections.

The Infection Control Market is primarily driven by the rise in surgical procedures requiring high-intensity infection prophylaxis. High preference is presumed to be a result of positive clinical outcomes associated with infection control use. The pandemic has positively impacted market growth. This is owing to the increasing demand for sterilization and disinfection in hospitals, and clinics, as well as pharmaceutical and medical device companies.

Factual Market Research Pvt Ltd provides comprehensive market research reports on various sectors, including infection control companies and the infectious disease diagnostics market. With a keen focus on the analysis of industry trends and market dynamics, our reports offer valuable insights into the global infection control market and the automatic identification and data capture market. Furthermore, they delve into the surface disinfectant market, aiding in the preparation of disinfectant products to enhance infection control measures. By examining the infectious disease diagnostics market, their reports contribute to strategic decision-making for companies operating in this sector.

Market Dynamics:

Drivers:

Recognizing the increasing burden of infectious diseases, governments and private health organizations are encouraging the adoption of infection control technologies across the globe. Additionally, rising awareness of environmental cleaning and disinfection and rising standards of effective cleaning are key market drivers. Moreover, the recent outbreak of coronavirus is providing lucrative growth for the Infection Control Market.

Restraints:

Long-term use of infection control products such as disinfectants and chemicals throughout a healthcare facility can lead to unavoidable problems. This includes deterioration the of objects when in direct contact with high concentrations of chemicals due to their toxicity. Chronic exposure can sometimes lead to chronic diseases and health problems such as cancer, respiratory irritation, headaches, mutagenic changes, and shortness of breath. These factors are likely to hamper the growth of the infection control market.

Opportunities:

With the increasing number of infection cases across the globe, there is a growing demand for solutions to address the causes of infection and reduce the risk of infection. Growing demand in the healthcare sector for products such as sterilization equipment, sterilizers, or consumables is expected to generate compensating revenues. In addition, as the number of surgeries increases, demand for gloves, sterilizers, and disposable products is expected to provide opportunities for Infection Control Market growth. Additionally, the rise in beautification-related surgeries is also expected to provide lucrative opportunities.

Key Players:

• STERIS

• Sotera Health Company

• Getinge AB

• Advanced Sterilization Products

• Ecolab Inc.

• 3M

• MATACHANA GROUP

• Belimed AG

• Reckitt Benckiser

• Metrex Research LLC

• Miele Group

• Pal International

• MELAG Medizintechnik GmbH & Co. KG

• Contec, Inc.

• MEDALKAN

• Systec GmbH

• C.B.M. S.r.l. Medical Equipment

• Continental Equipment Company

• BGS Beta-Gamma-Service GmbH & Co. KG

Market Segmentation:

Infection Control Market, By Product

• Sterilization

• Cleaning and Disinfection

• Personal Protective Barriers

• Endoscope Reprocessing

• Anti-Microbial Surfaces

• Others

 Infection Control Market, By End-user

• Hospitals

• Clinics

• Medical Device Companies

• Pharmaceutical and Biotechnology Companies

• Laboratories

• Others

Infection Control Market, By Region Type

• North America 

• Europe 

• Asia-Pacific 

• LAMEA 

Regional Analysis:

Infection control market was dominated by North America in 2021, which also had the biggest revenue share. The greater portion of this market is thought to be accounted for by a consistent number of strategic collaborations adopted by major industry competitors to increase their product portfolios and infection control capabilities. In addition, North America has gained a dominant share as established companies seek to expand their presence in the region.

During the projected period, the CAGR is anticipated to be the quickest in the Asia Pacific region. This is due to an increase in outsourcing companies, an increase in healthcare spending, and significant improvements in regional healthcare infrastructure and standards. One of the key elements influencing the expansion of the Asia Pacific area is the existence of numerous nonprofit and governmental organisations dedicated to raising infection control standards.

Scope of the report:

User

Tab Content